The science of vaccines is rapidly advancing — despite the anti-vax movement
Summary
Major pharmaceutical corporations are continuing to invest heavily in vaccine research despite challenging political conditions. Recent clinical data highlight promising developments in experimental treatments for cancer as well as new potential medical benefits linked to shingles immunization.
Look at the promising data for Moderna and Merck’s experimental cancer vaccine and the research suggesting the shingles vaccine can delay dementia.
Source: Read the full story at MarketWatch.com - Top Stories
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.